GlassScriptPhysician profile
Julia J Compton
NPI 1942435797
$430.49
in general payments reported to CMS, 2019-2025
14 companies · $72.05 in 2025
The $72.05 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.77 · 2021: $52.89 · 2022: $131 · 2024: $147 · 2025: $72.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $131.11 | 2019-2025 | |
| Coherus Oncology, INC. | $41.06 | 2021-2022 | |
| Eisai INC. | $34.64 | 2021-2022 | |
| Janssen Biotech, INC. | $29.06 | 2025 | Talvey, Darzalex |
| Boston Scientific Corporation | $27.56 | 2022-2024 | Spaceoar Vue System - 10ml |
| Siemens Medical Solutions USA, INC. | $26.04 | 2025 | Eclipse Treatment Planning System For External Beam Radiation Therapy, Truebeam |
| Servier Pharmaceuticals LLC | $24.15 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $18.01 | 2022 | |
| Myovant Sciences INC. | $17.76 | 2022 | |
| Exelixis INC. | $17.12 | 2024 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $16.81 | 2024 | Libtayo |
| Merck Sharp & Dohme LLC | $16.51 | 2019 | |
| Genentech USA, INC. | $15.49 | 2021 | |
| Sobi, INC | $15.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Compton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.